Precious Metals

[bladerunner1717]

gfp, KZIA is about as speculative as it gets. All the caveats about nano biotechs apply PLUS the caution that this is an Australian biotech.

My two largest positions in terms of number of shares are PRVB and MGTA. I'm underwater on both.

August through the first half of October are traditionally the worst months of the year for biotechs and the Market in general. KZIA is presenting at SNO in November in Austin. Then comes ASH and SABC in December. Those conferences tend to buoy the biotech sector.

KZIA market cap is around $75 millionUS.

There are 94 million shares out. 64 million are owned by Aussies. The other 30 million are in ADR's through Bank Mellon (3 million ADR's). The Aussie shares can be converted to ADR's (at the ratio of 10-to-1), if the demand in the U.S. is great enough.

Good luck.

Bladerunner